GSK plc (GS71)

16.380
+0.060(+0.37%)
  • Volume:
    84,329
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    16.160 - 16.480

GS71 Overview

Prev. Close
16.32
Day's Range
16.16-16.48
Revenue
25.78B
Open
16.26
52 wk Range
14.722-22.004
EPS
3.41
Volume
84,329
Market Cap
65.77B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
66,802
P/E Ratio
4.18
Beta
0.289
1-Year Change
-20.01%
Shares Outstanding
4,061,018,581
Next Earnings Date
-
What is your sentiment on GSK plc?
or
Market is currently closed. Voting is open during market hours.

GSK plc News

GSK plc Analysis

GSK plc Company Profile

GSK plc Company Profile

Employees
90096
  • Type:Equity
  • Market:Germany
  • ISIN:GB00BN7SWP63
  • WKN:A3DMB5

GSK plc is a global biopharma company. The Company makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions, including the chronic autoimmune condition lupus, respiratory disease, and human immunodeficiency virus (HIV). Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics and medicines for skin diseases. It has a global network of about 12 vaccines manufacturing sites.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • All export earners today are going south
    0
    • Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
      0
      • ITH stock
        0
        • Bought back all the gsk that I sold back in May. It's a no brainer at this price
          0
          • You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
            0
          • I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
            0
          • I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
            0
        • new management required
          0
          • Bloodbath coming
            3
            • Hi John, it will be worsth ?
              0
            • When will this carnage start, exacty (02/11/22)
              0
          • Should have taken the Unilever offer...
            0
            • It was madness not to.
              0
          • Demerger yet another damp squib in a long line of failures by Walmsley. She is unprecedented in her ability to talk the talk but to not walk the walk!
            2
            • This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
              2
              • Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
                4